Skip to main content
Top
Published in: Inflammation 2/2019

01-04-2019 | ORIGINAL ARTICLE

Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregulating TLR4

Authors: Zhi-Rong Ji, Wei-Liang Xue, Ling Zhang

Published in: Inflammation | Issue 2/2019

Login to get access

Abstract

To investigate the mechanism of Schisandrin B (Sch B) on the inflammation in LPS-induced sepsis. Sepsis mouse model was established by injecting LPS. qRT-PCR and western blot were used to measure the expression of miR-17-5p and TLR4. ELISA was used to test the concentrations of IL-1β and TNF-α. Sch B could increase miR-17-5p expression, promote inflammation, and decrease TLR4 expression in sepsis mice and LPS-induced macrophages. Moreover, miR-17-5p could negatively regulate TLR4. Overexpression of miR-17-5p suppressed the concentrations of inflammatory factors (IL-1β and TNF-α) in LPS induced-macrophages, while pcDNA-TLR4 could change the inhibition effect. Additionally, miR-17-5p inhibitor changed the inhibitory effects of Sch B on TLR4 expression and the concentrations of IL-1β and TNF-α in LPS induced-macrophages. Sch B could attenuate inflammation in LPS-induced sepsis through miR-17-5p downregulating TLR4.
Literature
1.
go back to reference Idrovo, J.P., W.L. Yang, A. Jacob, L. Corbo, J. Nicastro, G.F. Coppa, and P. Wang. 2016. Inhibition of lipogenesis reduces inflammation and organ injury in sepsis. The Journal of Surgical Research 200 (1): 242–249.CrossRefPubMed Idrovo, J.P., W.L. Yang, A. Jacob, L. Corbo, J. Nicastro, G.F. Coppa, and P. Wang. 2016. Inhibition of lipogenesis reduces inflammation and organ injury in sepsis. The Journal of Surgical Research 200 (1): 242–249.CrossRefPubMed
2.
go back to reference Piliponsky, A.M., A. Lahiri, P. Truong, M. Clauson, N.J. Shubin, H. Han, and S.F. Ziegler. 2016. Thymic stromal lymphopoietin improves survival and reduces inflammation in sepsis. American Journal of Respiratory Cell and Molecular Biology 55 (2): 264–274.CrossRefPubMedPubMedCentral Piliponsky, A.M., A. Lahiri, P. Truong, M. Clauson, N.J. Shubin, H. Han, and S.F. Ziegler. 2016. Thymic stromal lymphopoietin improves survival and reduces inflammation in sepsis. American Journal of Respiratory Cell and Molecular Biology 55 (2): 264–274.CrossRefPubMedPubMedCentral
3.
go back to reference Fortis, S., et al. 2015. Osteopontin is associated with inflammation and mortality in a mouse model of polymicrobial sepsis. Acta Anaesthesiologica Scandinavica 59 (2): 170–175.CrossRefPubMed Fortis, S., et al. 2015. Osteopontin is associated with inflammation and mortality in a mouse model of polymicrobial sepsis. Acta Anaesthesiologica Scandinavica 59 (2): 170–175.CrossRefPubMed
4.
go back to reference Kuzmich, N.N., et al. 2017. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel) 5 (4): E34.CrossRef Kuzmich, N.N., et al. 2017. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines (Basel) 5 (4): E34.CrossRef
5.
go back to reference Venancio, T.M., et al. 2016. CETP lowers TLR4 expression which attenuates the inflammatory response induced by LPS and polymicrobial sepsis. Mediators of Inflammation 2016: 1784014.CrossRefPubMedPubMedCentral Venancio, T.M., et al. 2016. CETP lowers TLR4 expression which attenuates the inflammatory response induced by LPS and polymicrobial sepsis. Mediators of Inflammation 2016: 1784014.CrossRefPubMedPubMedCentral
6.
go back to reference Xin, D.Q., Z.M. Hu, H.J. Huo, X.J. Yang, D. Han, W.H. Xing, Y. Zhao, and Q.H. Qiu. 2017. Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats. Molecular Medicine Reports 16 (1): 533–538.CrossRefPubMedPubMedCentral Xin, D.Q., Z.M. Hu, H.J. Huo, X.J. Yang, D. Han, W.H. Xing, Y. Zhao, and Q.H. Qiu. 2017. Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats. Molecular Medicine Reports 16 (1): 533–538.CrossRefPubMedPubMedCentral
7.
go back to reference Bunel, V., M.H. Antoine, J. Nortier, P. Duez, and C. Stévigny. 2014. Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro. Journal of Applied Toxicology 34 (12): 1311–1319.CrossRefPubMed Bunel, V., M.H. Antoine, J. Nortier, P. Duez, and C. Stévigny. 2014. Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro. Journal of Applied Toxicology 34 (12): 1311–1319.CrossRefPubMed
8.
go back to reference Zhu, N., et al. 2017. Schisandrin B prevents hind limb from ischemia-reperfusion-induced oxidative stress and inflammation via MAPK/NF-kappaB pathways in rats. BioMed Research International 2017: 4237973.PubMedPubMedCentral Zhu, N., et al. 2017. Schisandrin B prevents hind limb from ischemia-reperfusion-induced oxidative stress and inflammation via MAPK/NF-kappaB pathways in rats. BioMed Research International 2017: 4237973.PubMedPubMedCentral
9.
go back to reference Xu, J., C. Lu, Z. Liu, P. Zhang, H. Guo, and T. Wang. 2018. Schizandrin B protects LPS-induced sepsis via TLR4/NF-kappaB/MyD88 signaling pathway. American Journal of Translational Research 10 (4): 1155–1163.PubMedPubMedCentral Xu, J., C. Lu, Z. Liu, P. Zhang, H. Guo, and T. Wang. 2018. Schizandrin B protects LPS-induced sepsis via TLR4/NF-kappaB/MyD88 signaling pathway. American Journal of Translational Research 10 (4): 1155–1163.PubMedPubMedCentral
10.
go back to reference Chang, Z., Y. Zhong, and Y. Jia. 2017. The role of microRNAs in the occurrence and development of esophageal squamous cell carcinoma. Clinical Surgery Research Communications 1 (1): 1–9. Chang, Z., Y. Zhong, and Y. Jia. 2017. The role of microRNAs in the occurrence and development of esophageal squamous cell carcinoma. Clinical Surgery Research Communications 1 (1): 1–9.
11.
go back to reference Gao, X.L., J.Q. Li, Y.T. Dong, E.J. Cheng, J.N. Gong, Y.L. Qin, Y.Q. Huang, J.J. Yang, S.J. Wang, and D.D. An. 2018. Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model. Cytokine 110: 466–478.CrossRefPubMed Gao, X.L., J.Q. Li, Y.T. Dong, E.J. Cheng, J.N. Gong, Y.L. Qin, Y.Q. Huang, J.J. Yang, S.J. Wang, and D.D. An. 2018. Upregulation of microRNA-335-5p reduces inflammatory responses by inhibiting FASN through the activation of AMPK/ULK1 signaling pathway in a septic mouse model. Cytokine 110: 466–478.CrossRefPubMed
12.
go back to reference Cheng, Y.Y., et al. 2016. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer 15 (1): 44.CrossRefPubMedPubMedCentral Cheng, Y.Y., et al. 2016. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Molecular Cancer 15 (1): 44.CrossRefPubMedPubMedCentral
13.
14.
go back to reference Gu, J., D. Wang, J. Zhang, Y. Zhu, Y. Li, H. Chen, M. Shi, X. Wang, B. Shen, X. Deng, Q. Zhan, G. Wei, and C. Peng. 2016. GFRalpha2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. Cancer Letters 380 (2): 434–441.CrossRefPubMed Gu, J., D. Wang, J. Zhang, Y. Zhu, Y. Li, H. Chen, M. Shi, X. Wang, B. Shen, X. Deng, Q. Zhan, G. Wei, and C. Peng. 2016. GFRalpha2 prompts cell growth and chemoresistance through down-regulating tumor suppressor gene PTEN via Mir-17-5p in pancreatic cancer. Cancer Letters 380 (2): 434–441.CrossRefPubMed
15.
go back to reference Acosta-Herrera, M., F. Lorenzo-Diaz, M. Pino-Yanes, A. Corrales, F. Valladares, T.E. Klassert, B. Valladares, H. Slevogt, S.F. Ma, J. Villar, and C. Flores. 2015. Lung transcriptomics during protective ventilatory support in sepsis-induced acute lung injury. PLoS One 10 (7): e0132296.CrossRefPubMedPubMedCentral Acosta-Herrera, M., F. Lorenzo-Diaz, M. Pino-Yanes, A. Corrales, F. Valladares, T.E. Klassert, B. Valladares, H. Slevogt, S.F. Ma, J. Villar, and C. Flores. 2015. Lung transcriptomics during protective ventilatory support in sepsis-induced acute lung injury. PLoS One 10 (7): e0132296.CrossRefPubMedPubMedCentral
16.
go back to reference Pei, Z., and J. Wang. 2015. Propofol attenuates LPS-induced tumor necrosis factor-alpha, interleukin-6 and nitric oxide expression in canine peripheral blood mononuclear cells possibly through down-regulation of nuclear factor (NF)-kappaB activation. The Journal of Veterinary Medical Science 77 (2): 139–145.CrossRefPubMed Pei, Z., and J. Wang. 2015. Propofol attenuates LPS-induced tumor necrosis factor-alpha, interleukin-6 and nitric oxide expression in canine peripheral blood mononuclear cells possibly through down-regulation of nuclear factor (NF)-kappaB activation. The Journal of Veterinary Medical Science 77 (2): 139–145.CrossRefPubMed
17.
go back to reference Guo, M., et al. 2017. Comparative effects of schisandrin A, B, and C on acne-related inflammation. Inflammation 40 (6): 2163–2172.CrossRefPubMed Guo, M., et al. 2017. Comparative effects of schisandrin A, B, and C on acne-related inflammation. Inflammation 40 (6): 2163–2172.CrossRefPubMed
18.
go back to reference Lin, Q., X. Qin, M. Shi, Z. Qin, Y. Meng, Z. Qin, and S. Guo. 2017. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2. International Immunopharmacology 49: 142–147.CrossRefPubMed Lin, Q., X. Qin, M. Shi, Z. Qin, Y. Meng, Z. Qin, and S. Guo. 2017. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2. International Immunopharmacology 49: 142–147.CrossRefPubMed
19.
go back to reference Liu, N., J.X. Zheng, Y.S. Zhuang, Z.K. Zhou, J.H. Zhao, and L. Yang. 2017. Anti-inflammatory effects of Schisandrin B on LPS-stimulated BV2 microglia via activating PPAR-gamma. Inflammation 40 (3): 1006–1011.CrossRefPubMed Liu, N., J.X. Zheng, Y.S. Zhuang, Z.K. Zhou, J.H. Zhao, and L. Yang. 2017. Anti-inflammatory effects of Schisandrin B on LPS-stimulated BV2 microglia via activating PPAR-gamma. Inflammation 40 (3): 1006–1011.CrossRefPubMed
20.
go back to reference Cheng, Y., et al. 2018. Gallic acid-L-leucine conjugate protects mice against LPS-induced inflammation and sepsis via correcting proinflammatory lipid mediator profiles and oxidative stress. Oxidative Medicine and Cellular Longevity 2018: 1081287.PubMedPubMedCentral Cheng, Y., et al. 2018. Gallic acid-L-leucine conjugate protects mice against LPS-induced inflammation and sepsis via correcting proinflammatory lipid mediator profiles and oxidative stress. Oxidative Medicine and Cellular Longevity 2018: 1081287.PubMedPubMedCentral
22.
go back to reference Park, B.S., and J.O. Lee. 2013. Recognition of lipopolysaccharide pattern by TLR4 complexes. Experimental & Molecular Medicine 45: e66.CrossRef Park, B.S., and J.O. Lee. 2013. Recognition of lipopolysaccharide pattern by TLR4 complexes. Experimental & Molecular Medicine 45: e66.CrossRef
23.
go back to reference Xie, Z., Z. Guo, and J. Liu. 2018. Whey acidic protein/four-disulfide core domain 21 regulate sepsis pathogenesis in a mouse model and a macrophage cell line via the Stat3/toll-like receptor 4 (TLR4) signaling pathway. Medical Science Monitor 24: 4054–4063.CrossRefPubMedPubMedCentral Xie, Z., Z. Guo, and J. Liu. 2018. Whey acidic protein/four-disulfide core domain 21 regulate sepsis pathogenesis in a mouse model and a macrophage cell line via the Stat3/toll-like receptor 4 (TLR4) signaling pathway. Medical Science Monitor 24: 4054–4063.CrossRefPubMedPubMedCentral
24.
go back to reference Mogilyansky, E., and I. Rigoutsos. 2013. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death and Differentiation 20 (12): 1603–1614.CrossRefPubMedPubMedCentral Mogilyansky, E., and I. Rigoutsos. 2013. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death and Differentiation 20 (12): 1603–1614.CrossRefPubMedPubMedCentral
25.
go back to reference Coucha, M., I.N. Mohamed, S.L. Elshaer, O. Mbata, M.L. Bartasis, and A.B. el-Remessy. 2017. High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: role of endoplasmic-reticulum-stress. World Journal of Diabetes 8 (2): 56–65.CrossRefPubMedPubMedCentral Coucha, M., I.N. Mohamed, S.L. Elshaer, O. Mbata, M.L. Bartasis, and A.B. el-Remessy. 2017. High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: role of endoplasmic-reticulum-stress. World Journal of Diabetes 8 (2): 56–65.CrossRefPubMedPubMedCentral
26.
go back to reference Chen, D., B.J. Dixon, D.M. Doycheva, B. Li, Y. Zhang, Q. Hu, Y. He, Z. Guo, D. Nowrangi, J. Flores, V. Filippov, J.H. Zhang, and J. Tang. 2018. IRE1alpha inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats. Journal of Neuroinflammation 15 (1): 32.CrossRefPubMedPubMedCentral Chen, D., B.J. Dixon, D.M. Doycheva, B. Li, Y. Zhang, Q. Hu, Y. He, Z. Guo, D. Nowrangi, J. Flores, V. Filippov, J.H. Zhang, and J. Tang. 2018. IRE1alpha inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats. Journal of Neuroinflammation 15 (1): 32.CrossRefPubMedPubMedCentral
Metadata
Title
Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregulating TLR4
Authors
Zhi-Rong Ji
Wei-Liang Xue
Ling Zhang
Publication date
01-04-2019
Publisher
Springer US
Published in
Inflammation / Issue 2/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0931-3

Other articles of this Issue 2/2019

Inflammation 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.